Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 3Completed 2Active not recruiting 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 44Squamous Cell Carcinoma of Head and Neck 19Breast Neoplasms 18Lung Neoplasms 17Colorectal Neoplasms 15Neoplasms 12Neoplasm Metastasis 12Head and Neck Neoplasms 12Ovarian Neoplasms 11Small Cell Lung Carcinoma 9Recurrence 9Sarcoma 8Pancreatic Neoplasms 8Prostatic Neoplasms 7Advanced Solid Tumors 7Urinary Bladder Neoplasms 6Triple Negative Breast Neoplasms 6Melanoma 6Lymphoma, Large B-Cell, Diffuse 6Diabetes Mellitus, Insulin-Dependent, 12 6Uterine Cervical Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Biliary Tract Neoplasms 5Mesothelioma, Malignant 4Lymphoma, Follicular 4Lymphoma 4Fallopian Tube Neoplasms 4Esophageal Neoplasms 4Cholangiocarcinoma 4

Interventions

Gemcitabine 34Cisplatin 21Capecitabine 18Oxaliplatin 15Leucovorin 10Fluorouracil 10Irinotecan 8Erlotinib Hydrochloride 7pembrolizumab 5Bevacizumab 5Radiotherapy 4Carboplatin 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4Watchful Waiting 3Taxes 3Sorafenib 3Platinum 3Interleukin-12 Subunit p35 3Immunohistochemistry 3Docetaxel 31,2-diaminocyclohexaneplatinum II citrate 3trifluridine tipiracil drug combination 2tremelimumab 2regorafenib 2durvalumab 2dehydroftorafur 2Trastuzumab 2Paclitaxel 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Gallbladder Neoplasms × durvalumab × Clear all
NCT05239169 2025-05-01

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed
40 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT03473574 2023-06-15

IMMUCHEC

AIO-Studien-gGmbH

Phase 2 Completed
128 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡